doc-icon

The Challenge

The vast majority of people living with epilepsy and associated psychiatric disorders in the developed world have their disorders controlled, typically with medication. But patients in the rest of the world go without these diagnostic tools, effective treatments and basic medications.

money-icon

The Process

The ROW Foundation is pursuing change. The ROW Foundation is a shareholder of OWP Pharmaceuticals, a for-profit company that produces neurology and psychiatry medications. Profits from OWP fund the charitable projects of ROW. Working together, the two organizations are an expression of sustainable philanthropy that can change the world.

kit-icon

The Solution

The ROW Foundation provides treatment resources, including proven medications, to people with epilepsy and associated psychiatric disorders. ROW also helps neurologists and psychiatrists in the developed world train practitioners in the developing world to more effectively treat epilepsy and associated psychiatric disorders.

We share the World Health Organization's belief that, “the highest attainable standard of health as a fundamental right of every human being.” In that spirit, we're working toward a world in which the same standard of care for epilepsy and associated psychiatric disorders is available to all people, at all times, in all the world.

Vision

The ROW Foundation exists to improve the lives of people living with epilepsy and associated psychiatric disorders in under-resourced areas of the world. We envision a future when the best treatments will be available to all people, at all times, in all the world.

Mission

In fulfilling our vision, the ROW Foundation works to improve the quality of training, diagnosis and treatment available to people with epilepsy and associated psychiatric disorders in under-resourced areas of the world. We partner with other organizations to maximize impact in under-served areas, both domestically and internationally.

row-vision-mission

Subscribe to Receive Monthly Updates


By submitting this form, you are consenting to receive marketing emails from: ROW Foundation, 931 W. Hawthorne Lane, West Chicago, IL, 60185, http://rowpharma.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Receive a free e-version of our new book, One World One Standard

One World. One Standard.®

The map shows our completed, ongoing and future projects. Click on highlighted countries to see what we’re doing around the world.

Completed Projects
Ongoing Projects
Future Projects
Multiple Projects

Diagnosis and Treatment Grants (Multiple)

In 2015 a diagnosis grant in the form of a 32-channel video EEG workstation was given to the Armenia League Against Epilepsy, to be placed at Arabkir Pediatric Hospital in the capital city of Yerevan. Beginning in October 2016, an ongoing treatment grant has been supplying the hospital with Roweepra® (levetiracetam USP) anti-seizure medication. This is an ongoing commitment of medication, to be resupplied every six months.

Treatment Grant (Ongoing)

In 2018, a treatment grant of Roweepra® (levetiracetam USP) was provided to Solidarity Bridge/Puente Solidaridad for use in the nation’s first comprehensive epilepsy center at Belga Hospital in Cochabamba, Bolivia. This is an ongoing commitment of medication, to be resupplied as needed.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant mobile EEG equipment to assist with the diagnosis and monitoring of epilepsy patients in outlying, under-resourced areas of Cameroon. When the grant is fully implemented, EEG scans will be able to be transmitted via the internet and read by volunteer neurologists in the United States, who can then provide diagnoses to health care providers in Cameroon.

Training Grant (Future)

The ROW Foundation hopes to partially fund a new neuro-diagnostic training program at a university in northern Cameroon.

Training Grant (Completed)

In 2017, a training grant was provided to the Global Organization of Health Education (GOHE) for the purchase of technical materials to be used in training EEG technicians at Mekelle University in Ethiopia.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to an epilepsy society headquartered in Accra, Ghana for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Accra area. The epilepsy society will make the equipment available through various clinics and coordinate its use.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 64-channel video EEG workstation to a neurology center in Guatemala City, Guatemala to assist with diagnosing and monitoring patients with epilepsy due to traumatic brain injury, and patients with forms of epilepsy resistant to typical forms of treatment.

Treatment Grant (Ongoing)

In 2017, a treatment grant was provided to Children’s Hope, a US-based nonprofit operating a medical/dental clinic in Jacmel. This grant provides Roweepra® (levetiracetam USP) for epilepsy patients being treated through the clinic. This is an ongoing commitment of medication, to be resupplied as needed.

Treatment Grant (Ongoing)

In 2018 a treatment grant of Roweepra® (levetiracetam USP) anti-seizure medication was provided to the CLIDEP Epilepsy Clinics in Haiti to augment medications available locally for treating patients with epilepsy. Initially the medication will be used for the CLIDEP clinics in Port-au-Prince and Jacmel, with possible expansion to the clinic in Mirebalais as well. This is an ongoing commitment of medication, to be resupplied every six months as needed.

Treatment Grant (Ongoing)

In 2018, a treatment grant was provided to Concerned Haitian Americans of Illinois (CHAI), a US-based nonprofit operating a medical clinic in a rural area near Cap-Haitien. This grant provides Roweepra® (levetiracetam USP) for epilepsy patients being treated through the clinic and students from CHAI’s two schools. This is an ongoing commitment of medication, to be resupplied as needed.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant mobile EEG equipment to two rural hospitals in India. When the grants are fully implemented, EEG scans will be able to be transmitted via the internet and read by volunteer neurologists in the United States, who can then provide diagnoses to health care providers at the hospitals in India.

Diagnosis Grant (Completed)

In 2018, the ROW Foundation granted funds to Santokba Durlabhji Memorial Hospital for the purchase of a portable 32-channel video EEG workstation in Jaipur, India. This EEG will be used in the pediatric ICU for diagnosis and monitoring of epilepsy for children in the greater Jaipur area.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation provided a treatment grant of Roweepra® (levetiracetam USP) anti-seizure medication to the Kenya Association for the Welfare of People with Epilepsy. This is an ongoing commitment of medication.

Diagnosis Grant (Completed)

In 2016, mobile EEG equipment was provided to AIC Kijabe Hospital, a rural hospital in the Great Rift Valley of Kenya that had no EEG equipment, and no resident neurologists to read EEG studies. Through a grant to the Christian Medical and Dental Associations (CMDA), the equipment was placed, hospital staff were trained, and a mechanism for transmitting the EEG studies to volunteer neurologists in the United States was established. This allows volunteer neurologists to make diagnoses based on the EEG study data and to communicate with the health care providers at the hospital in Kenya who then provide treatment. Leveraged partnerships also resulted in a duplicate project at Tenwek Hospital.

Diagnosis Grant (Future)

The ROW Foundation hopes to fund an epilepsy support organization to expand their ongoing telehealth program in western Nepal.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to a hospital in Abakaliki, Nigeria for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Abakaliki area.

Training Grant(Completed)

In 2018, a grant was provided to the Global Organization for Health Education (GOHE) for trainers attending the first annual African Neurophysiology Annual Conference in Lagos. This event offers training for neurodiagnostic professionals from across Africa.

Diagnosis Grant (Complete)

In 2018, a diagnosis grant in the form of a 32-channel video EEG workstation was given to the Georgian League Against Epilepsy, to be placed at the Institute for Neurology and Neuropsychology in Tbilisi. The new EEG workstation will allow the institute to diagnose under-resourced individuals with hard-to-treat epilepsies.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation started providing anti-seizure medication to Loreto Clinic in the city of Makeni. Roweepra® (levetiracetam USP) anti-seizure medication augments locally available medication for treating patients with epilepsy. This medication grant is only possible through ROW’s partnership with the Healey International Relief Foundation.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation provided Roweepra® (levetiracetam USP) for Medical Assistance Sierra Leone (MASL), a UK-based organization. In 2010, MASL and local partners established the first clinical epilepsy service in Sierra Leone. The supply is dispensed by Epilepsy Association Sierra Leone and will be replenished as needed.

Shipment of this grant was made possible by the Healey International Relief Foundation. 

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to an epilepsy society in Mbabane, Swaziland for use in diagnosing and monitoring epilepsy patients in outlying, under-resourced areas.

Treatment Grant (Completed)

In 2017, a grant was provided to the Guiding Light Orphans (GLO) organization in Uganda to assist with the purchase of locally-available anti-seizure medications, and to support operation of their mobile epilepsy clinics.

Treatment Grant (Ongoing)

In 2017, a treatment grant was provided to CURE Children’s Hospital of Uganda, located in Mbale. This grant provides Roweepra (levetiracetam USP) to augment the locally available medications available for treating patients with epilepsy. This is an ongoing commitment of medication, to be resupplied every six months.

Treatment Grant (Completed)

In 2016, a grant was provided to Epilepsy Health Management (EHM) to assist with modifications to a local epilepsy clinic in northern Illinois that will allow epilepsy patients with mobility issues – often as a result of traumatic brain injury – access services more easily.

Treatment Grant (Ongoing)

In 2017, treatment grants were made to two Epilepsy Foundation chapters in the United States: one to the Epilepsy Foundation of North Carolina, and the other to the Epilepsy Foundation of North/Central Illinois. The grants consisted of Roweepra® (levetiracetam USP) and are being used to provide care for epilepsy patients temporarily unable to access care independently. The ROW Foundation is open to providing similar treatment grants to Epilepsy Foundations operating treatment clinics and serving under-resourced populations.

Treatment Grant (Completed)

In October 2017 ROW partnered with the Epilepsy Foundation of Greater Chicago and Dr. Rebecca Garcia Sosa of Lurie Children’s Hospital in Chicago to deliver a medication humanitarian aid shipment to Hospital Pediátrico Universitario (HOPU) in San Juan , Puerto Rico in the aftermath of Hurricane Maria. HOPU had been designated as a central hub for the receipt of medication humanitarian relief, and Dr. Janice Rodriguez Hernandez, Child Neurology Chief Resident, Fundación Hospital Pediátrico, was responsible for coordinating the distribution of the medication to where it was most needed until commercial pharmaceutical distribution could be restored.

Treatment Grant (Completed)

In 2018, the ROW Foundation made grants of Roweepra® (levetiacetam USP) to three organizations that provide medical relief in the U.S. and around the world. These grants totaled $2.6 million (wholesale value).

Treatment Grant (Completed)

In 2018, the ROW Foundation granted 284 cases of Roweepra® (levetiracetam USP) to Cuatro por Venezuela. This emergency humanitarian aid was dispensed by the Venezuelan League Against Epilepsy (LIVECE).

Training Grant (Future)

The ROW Foundation hopes to partially fund neuro-diagnostic technician training at an epilepsy association in Harare.

Recent Updates

October 18, 2018

Amazing Victory – One of Many!

FATIMA HAS HAD EPILEPSY since the age of three. For 30 years the treatment available to her did not control her seizures. She recently made a 150-mile trip to the epilepsy clinic in Freetown. She was diagnosed with epilepsy and received Roweepra through one of our partners, Medical Assistance Sierra Leone (MASL).
September 20, 2018

The Republic of Georgia

THE REPUBLIC OF GEORGIA is the location of ROW’s latest equipment grant. Georgia shares a border with Armenia, the location of our very first grant in 2015. Now we’re providing the same Natus Neurology 32-channel video EEG workstation to the Georgian League Against Epilepsy.
August 23, 2018

$2 Million In Life-Saving Medication!

The ROW Foundation has surpassed the $2 million mark in medication grants to alleviate the suffering caused by epilepsy. Thousands of people in places like Sierra Leone, Haiti, Armenia, Bolivia, and Venezuela have new hope for a brighter future. And we’re just getting started!

Make Your Mark

Your charitable contributions allow you to make your mark on the world!

Make Your Mark!
shares